Leigh Precopio

research summary
research summary
06/18/2024
Leigh Precopio
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
06/18/2024
research summary
research summary
05/20/2024
Leigh Precopio
Researchers examined the epidemiology of hydroxymethylbilane synthase (HMBS) gene defects and activity levels among patients with acute intermittent porphyria to better understand the role of HMBS activity...
05/20/2024
conference coverage
conference coverage
05/24/2024
Leigh Precopio
Researchers examined how the use of spinal anesthesia in those undergoing lumbar spine surgery reduced the use of polypharmacy and opioids, and ultimately the risk of adverse events, in older adults.
05/24/2024
research summary
research summary
02/28/2024
Leigh Precopio
Individuals with primary hyperoxaluria type 1 are at an increased risk of urinary stone disease, nephrocalcinosis, and chronic kidney disease due to increased hepatic oxalate production. Researchers...
02/28/2024
research summary
research summary
04/19/2024
Leigh Precopio
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
04/19/2024
conference coverage
conference coverage
01/31/2024
Leigh Precopio
Individuals with HIV are at higher risk of severe disease from COVID-19. In a recent study, researchers aimed to examine the factors that influence COVID-19 vaccine uptake in this patient population.
01/31/2024
research summary
research summary
11/30/2023
Leigh Precopio
Individuals with acute myeloid leukemia often have low levels of vitamin C and vitamin D at the time of diagnosis. Researchers examined how supplementation of these vitamins during treatment impacted...
11/30/2023
research summary
research summary
10/26/2023
Leigh Precopio
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
10/26/2023
research summary
research summary
10/30/2023
Leigh Precopio
Researchers examined trends and patterns of emergency department visits and hospitalizations for suicidality among pediatric patients.
10/30/2023
fda alert
fda alert
10/19/2023
Leigh Precopio
The FDA approved the use of quizartinib for certain patient populations with acute myeloid leukemia in July 2023.
10/19/2023